NBIX
#689
Neurocrine Biosciences, Inc. - Common Stock
155.9 2 USD
0.00%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.43%
Monthly Change
-14.33%
6 month change
+19.64%
Year Change
+7.53%
Previous Close
156.5 9
Open
155.9 2
Low
155.9 2
High
155.9 2
Volume
142
Financials
- Market Capitalization 15.85 B
- Employee 2 500
- Founded 1992
- CEO Kevin C. Gorman
- Website www.neurocrine.com
- Headquarter Delaware, United States
- FIGI BBG000GJS7C1
- Industry Drug Manufacturers—Specialty & Generic
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
30.37
Price to sales ratio
5.08
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 479 |  TAK Takeda Pharmaceutical Company Limited American Depositary Share | 18.04 USD | -1.15% | -0.39% | +1.81% | +27.18% | 28.10 B USD | ||
| 613 |  VTRS Viatris Inc. - Common Stock | 16.89 USD | +0.24% | +5.50% | -5.96% | +63.19% | 19.40 B USD | ||
| 820 |  ELAN Elanco Animal Health Incorporated Common Stock | 24.51 USD | -2.23% | +3.46% | -4.67% | +9.44% | 12.25 B USD | ||
| 918 |  RDY Dr. Reddy's Laboratories Ltd | 12.15 USD | -0.57% | +0.16% | +3.23% | -14.07% | 10.14 B USD |
Frequently asked questions about Neurocrine Biosciences Inc
What is the Neurocrine Biosciences Inc stock price today?
The current price of Neurocrine Biosciences Inc (NBIX) is 155.92. Over the past 24 hours, the stock has changed by -0.43%. Follow the NBIX chart for real-time price dynamics.
What is the stock ticker of Neurocrine Biosciences Inc?
Neurocrine Biosciences Inc trades under the ticker NBIX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Neurocrine Biosciences Inc stock going up?
NBIX has changed by +1.82% over the last week, -14.33% over the last month, and +7.53% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Neurocrine Biosciences Inc?
Neurocrine Biosciences Inc currently has a market capitalization of 15.85 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Neurocrine Biosciences Inc earnings last quarter?
Last quarter, Neurocrine Biosciences Inc reported earnings of 1.43 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Neurocrine Biosciences Inc revenue for the last quarter?
Neurocrine Biosciences Inc reported quarterly revenue of 959 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Neurocrine Biosciences Inc net income for the last quarter?
Neurocrine Biosciences Inc reported net income of 144.4 M for the last quarter. The previous quarter showed 197.9 M, which means net income changed by -27.03%.
How many employees does Neurocrine Biosciences Inc have?
As of the latest available data, Neurocrine Biosciences Inc has 2 500 employees. Workforce size can provide additional context about the company's scale and operations.
What is Neurocrine Biosciences Inc EBITDA?
Neurocrine Biosciences Inc EBITDA is 176 M, and its EBITDA margin is 18.35%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Neurocrine Biosciences Inc stock?
You can buy Neurocrine Biosciences Inc (NBIX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Neurocrine Biosciences Inc stock?
Investing in Neurocrine Biosciences Inc requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NBIX chart and related analysis on metatrader.com as part of your research.